Showing results (1-10 of 82) with videos related to
Sort By:
Pageof 9
Current Opinion in Supportive and Palliative Care|July 7, 2023
Supportive care for chimeric antigen receptor T-cell patientsDeborah Springell, Maeve O'Reilly, Claire RoddieThe Lancet. Infectious Diseases|February 4, 2024
Mucormycosis after CD19 chimeric antigen receptor T-cell therapy: results of a US Food and Drug Administration adverse events reporting system analysis and a review of the literatureKathleen P L Cheok, Adrian Farrow, Deborah Springell, et al.Cytotherapy|January 28, 2019
Manufacturing chimeric antigen receptor T cells: issues and challengesClaire Roddie, Maeve O'Reilly, Juliana Dias Alves Pinto, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 4, 2025
Neurotoxic complications of chimeric antigen receptor (CAR) T-cell therapyFrederick W Vonberg, Imran Malik, Maeve O'Reilly, et al.Ejhaem|October 17, 2024
Single-centre experience of implementing physiotherapist-led prehabilitation for chimeric antigen receptor T cell therapyOrla McCourt, Paul Maciocia, Claire Roddie, et al.Haematologica|April 30, 2025
Clonal evolution and the risk of secondary myeloid neoplasia following chimeric antigen receptor T-cell therapyFrancesca Sillito, Alexandros Rampotas, Kathleen Cheok, et al.Ejhaem|December 18, 2024
CD19-targeting chimeric antigen receptor T-cell therapy is safe and effective for intra-cardiac B cell non-Hodgkin lymphomaDaniel H Chen, Maeve O'Reilly, Kathleen P Cheok, et al.Haematologica|April 2, 2026
CAR-T therapy for relapsed/refractory large B-cell lymphoma in people living with HIV: efficacy, toxicity and treatment considerationsAngela Hwang, Amy A Kirkwood, Prudence Hardefeldt, et al.Blood|September 24, 2024
The present and future of CAR T-cell therapy for adult B-cell ALLAlexandros Rampotas, Claire RoddieHemasphere|March 4, 2024
High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphomaMaeve A O'Reilly, Lorna Neill, Simon M Collin, et al.Pageof 9